Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Estrogen therapy can reduce skin aging but has cancer risks.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Lecithin-encapsulated resveratrol nanoparticles could be a safe and effective anti-cancer treatment.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

Activating ER-β, not ER-α, improves skin cell growth and wound healing.

Ginseng may help treat cancer and reduce treatment side effects, but more research is needed.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.